This website uses cookies to improve your experience. Continue if you are OK with this or read more in our privacy policy. 

US appeals court upholds AstraZeneca’s Seroquel XR patent


The US Court of Appeals for the Federal Circuit has affirmed a 2012 ruling that AstraZeneca’s patent for blockbuster antipsychotic drug Seroquel XR is valid and has been infringed by companies selling competing generics.

AstraZeneca, Seroquel XR, Mylan, Torrent, Osmotica, infringement


Payment types accepted